Sign up
Quantellect · Congress · Trade Detail
TRHCTabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale.
DemocratHouse

Tom Malinowski sold Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC)

Tom Malinowski (D-NJ), a U.S. Representative, has disclosed 4 trades in Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC) since 2019, 2 purchases and 2 sales, worth an estimated $32K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Tom Malinowski sold $1,001 - $15,000 of Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC) on November 12, 2019. Since that trade, TRHC is up +0.00% against the S&P 500 up +159.60%, an outperformance of -159.60%.

Across these filings, Tom Malinowski has been a balanced trader of TRHC (a buy-to-sell ratio of 1.00). The most recent disclosed TRHC transaction shown was dated November 13, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

TRHC trades
4
Disclosed Vol
$32K
Buys
2
50%
Sells
2
50%
Buy / Sell
1.00
ratio
First → Last
2019

Tom Malinowski's TRHC trades vs the price

TRHC is up +0.00% since Tom Malinowski sold on November 12, 2019, versus +159.60% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+159.60%
Outperformance vs S&P 500
-159.60%

All Tom Malinowski TRHC trades

TradedTypeSizeReturnEst. profit
November 13, 2019BUY$1,001 - $15,000N/A
November 12, 2019SELL$1,001 - $15,000N/A
November 8, 2019SELL$1,001 - $15,000N/A
November 7, 2019BUY$1,001 - $15,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Tom Malinowski & TRHC trading FAQ

Is it legal for Tom Malinowski to trade Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Tom Malinowski sell TRHC?

Tom Malinowski disclosed a sale of $1,001 - $15,000 of Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC) on November 12, 2019, according to public STOCK Act filings.

How has TRHC performed since Tom Malinowski's trade?

Since Tom Malinowski sold TRHC on November 12, 2019, the stock is up +0.00%, versus +159.60% for the S&P 500 over the same period, an outperformance of -159.60%.

How many times has Tom Malinowski traded TRHC?

Tom Malinowski has disclosed 4 TRHC trades since 2019 (2 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional TRHC trades?

Quantellect tracks every disclosed congressional trade in Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. (TRHC) on the Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale. congressional trading page, which aggregates filings across all members of Congress.

Tom Malinowski's TRHC tradesAll congressional filings for Tabula Rasa HealthCare, Inc. (TRHC) [ST] F IlINg S TATuS : New D ESCRIPTION : Short Sale.Tom Malinowski's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.